CytoSorbents Q3 Adj. EPS $(0.48) Beats $(0.90) Estimate, Sales $9.728M Miss $9.915M Estimate
Benzinga Newsdesk 1 week ago
NewsEarningsEarnings BeatsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.90) by 46.67 percent. This is a 40 percent increase over losses of $(0.80) per share from the
CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.90) by 46.67 percent. This is a 40 percent increase over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of $9.728 million which missed the analyst consensus estimate of $9.915 million by 1.88 percent. This is a 2.56 percent increase over sales of $9.485 million the same period last year.
